Tandem Diabetes Care
TNDM
75 hedge funds and large institutions have $26.2M invested in Tandem Diabetes Care in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 19 closing their positions.
3.98% more ownership
Funds ownership: 0% → 3.98% (+4%)
4% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 24
11% less funds holding
Funds holding: 84 → 75 (-9)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
70% less call options, than puts
Call options by funds: $22K | Put options by funds: $73K
81% less capital invested
Capital invested by funds: $136M → $26.2M (-$109M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.31M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$737K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$654K |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$545K |
| 5 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
+$379K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$9.63M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.53M |
| 3 |
Millennium Management
New York
|
-$6.28M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$4.54M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$3.49M |
TNDM Hedge Fund Activity: Q4 2016 in Review
75 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2016, worth a combined $26.2M — down 81% from $136M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of TNDM and 11 opened new positions — a net loss of 8 holders — while 24 trimmed existing stakes and 25 added.
The largest buyer was Bank of America, adding an estimated $1.31M. The largest seller was Franklin Resources, exiting entirely with an estimated $9.63M sold.
- 75 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2016, down from 84 in Q3 2016.
- Funds reported $26.2M of Tandem Diabetes Care stock for Q4 2016, down 81% quarter-over-quarter.
- 11 funds opened new Tandem Diabetes Care positions in Q4 2016 and 19 closed out, a net change of -8 holders.
- The largest Tandem Diabetes Care buyer in Q4 2016 was Bank of America, an estimated $1.31M added.
- The largest Tandem Diabetes Care seller in Q4 2016 was Franklin Resources, an estimated $9.63M sold.
Based on aggregated 13F filings for Q4 2016.